American Initiative in Mast Cell Diseases logo

ARUP Laboratories is sponsoring the American Initiative in Mast Cell Diseases Physician and Investigator Conference, and our experts look forward to connecting with attendees at the meeting.

May 14, 2026

ARUP Laboratories is sponsoring the American Initiative in Mast Cell Diseases (AIM) 2026 Physician and Investigator Conference, May 16 and 17, in Ann Arbor, Michigan. Our experts, including Tracy George, MD, chief scientific officer, president of the Innovation Business Unit, and medical director of Hematopathology, will be available to connect with attendees at our booth.

Review the list below for the presentation schedule and details on poster presentations by ARUP experts.

Presentations

Saturday, May 16

Session 2: Classification, Pathology, and Molecular Biology

Germline Predisposition in Advanced Systemic Mastocytosis | 10:40 a.m. (EDT)

Presented by Peng Li, MD, PhD, medical director of Hematopathology

Plenary Presentation Introduction | 1:05 p.m. (EDT)

Presented by Tracy George, MD

Sunday, May 17

Special Session: Multidisciplinary Interactive Tumor Board | 8:40 a.m. (EDT)

Anton Rets, MD, PhD, medical director of Hematopathology, will participate as a session chair.

Posters

TPSAB1 Copy Number Testing: Genotypic Diversity, KIT Mutation, and Tryptase Correlation

Ryan Shean, DO

Coauthors: Malia Deshotel, PhD; Peng Li, MD, PhD; Kristin Karner, MD; Abdulrahman Saadalla, MB, BCh; Anton Rets, MD, PhD; Margaret Williams, MD; Tracy George, MD; and Anna Shestakova, MD, PhD

Performance of Immunohistochemical Detection of CD123 Expression on Mast Cells in Systemic Mastocytosis

Kate Parkinson, MD

Coauthors: Tracy George, MD; Ryan Shean, DO; and Anton Rets, MD, PhD

Normalization of Bone Marrow Disease Avapritinib in Patients With Advanced Systemic Mastocytosis: Pooled Analysis From the EXPLORER and PATHFINDER Studies

Tracy George, MD

Coauthors: Anton Rets, MD, PhD; Kristin Karner, MD; and Karen Moser, MD

Disease Modifying Effects of Avapritinib on Bone Turnover Markers (BTMs) and Bone Disease in Patients With Advanced Systemic Mastocytosis (AdvSM)

Tracy George, MD

Learn how laboratory testing at ARUP improved life for a patient with indolent systemic mastocytosis.

 

Bonnie Stray, bonnie.stray@aruplab.com